These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8525285)

  • 1. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
    Awadzi K; Opoku NO; Addy ET; Quartey BT
    Trop Med Parasitol; 1995 Jun; 46(2):131-7. PubMed ID: 8525285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
    Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
    Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
    Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
    Duke BO
    Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
    Tagboto SK; Townson S
    Ann Trop Med Parasitol; 1996 Oct; 90(5):497-505. PubMed ID: 8915126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
    Awadzi K; Dadzie KY; Kläger S; Gilles HM
    Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin.
    Cooper PJ; Awadzi K; Ottesen EA; Remick D; Nutman TB
    J Infect Dis; 1999 Mar; 179(3):738-42. PubMed ID: 9952390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
    Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
    Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
    Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT
    Trans R Soc Trop Med Hyg; 1999; 93(2):189-94. PubMed ID: 10450448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerance of ivermectin in human onchocerciasis.
    Aziz MA; Diallo S; Diop IM; Lariviere M; Porta M
    Lancet; 1982 Jul; 2(8291):171-3. PubMed ID: 6123884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
    Mössinger J; Schulz-Key H; Dietz K
    Trop Med Parasitol; 1988 Dec; 39(4):313-6. PubMed ID: 3067322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
    Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
    Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
    Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
    Taylor HR; Murphy RP; Newland HS; White AT; D'Anna SA; Keyvan-Larijani E; Aziz MA; Cupp EW; Greene BM
    Arch Ophthalmol; 1986 Jun; 104(6):863-70. PubMed ID: 3521559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.